Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review
- 2 June 2016
- journal article
- review article
- Published by Wiley in Alcohol: Clinical and Experimental Research
- Vol. 40 (7), 1390-1402
- https://doi.org/10.1111/acer.13108
Abstract
Alcoholic hepatitis (AH) occurs in about one-third of individuals reporting long-term heavy alcohol use. It is associated with high short-term mortality, economic burden, and hospital resources utilization. We performed this systematic review to (i) describe clinical characteristics and genomics associated with the risk of AH; (ii) discuss role and limitations of liver biopsy and prognostic scoring systems; (iii) summarize evidence regarding the currently available therapies including liver transplantation; and (iv) outline emerging therapies with areas of unmet need. Literature search was performed for studies published in English language (January 1971 through March 2016). The following search engines were used: PubMed, Elsevier Embase, PsycINFO, and Cochrane Library. For the treatment section, only randomized controlled studies were included for this review. A total of 138 studies (59 randomized, 22 systematic reviews or meta-analyses, 7 surveys or guidelines, 7 population-based, and 43 prospective cohorts) were cited. There are over 325,000 annual admissions with AH contributing to about 0.8% of all hospitalizations in the United States. Liver biopsy may be required in about 25 to 30% cases for uncertain clinical diagnosis. Corticosteroids with or without N-acetylcysteine remains the only available therapy for severe episodes. Data are emerging on the role of liver transplantation as salvage therapy for select patients. Abstinence remains the most important factor impacting long-term prognosis. Results from the ongoing clinical trials within the National Institute on Alcohol Abuse and Alcoholism-funded consortia are awaited for more effective and safer therapies. AH is a potentially lethal condition with a significant short-term mortality. A high index of suspicion is required. There remains an unmet need for noninvasive biomarkers for the diagnosis, and predicting prognosis and response to therapy.Keywords
Funding Information
- National Institutes of Health (1R21AA023273-01A)
This publication has 127 references indexed in Scilit:
- White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkersBMC Gastroenterology, 2013
- Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physiciansWorld Journal of Gastrointestinal Pharmacology and Therapeutics, 2013
- Colonic microbiome is altered in alcoholismAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Alcoholic Hepatitis: Prognostic Models and TreatmentGastroenterology Clinics of North America, 2011
- Antioxidants as therapeutic agents for liver diseaseLiver International, 2011
- Pentoxifylline Does Not Decrease Short-term Mortality but Does Reduce Complications in Patients With Advanced CirrhosisGastroenterology, 2010
- Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in ratsJournal of Hepatology, 2009
- A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic HepatitisGastroenterology, 2008
- Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and PrednisoloneThe New England Journal of Medicine, 1984
- Experimental Alcoholic Hepatitis: A New Primate ModelScience, 1973